Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors

Por Traber, Peter G., Zomer, Eliezer
Publicado em 2013

Regression of Fibrosis and Reversal of Cirrhosis in Rats by Galectin Inhibitors in Thioacetamide-Induced Liver Disease

Por Traber, Peter G., Chou, Hsin, Zomer, Eliezer, Hong, Feng, Klyosov, Anatole, Fiel, Maria-Isabel, Friedman, Scott L.
Publicado em 2013

Binding of polysaccharides to human galectin-3 at a noncanonical site in its carbohydrate recognition domain

Por Miller, Michelle C, Ippel, Hans, Suylen, Dennis, Klyosov, Anatole A, Traber, Peter G, Hackeng, Tilman, Mayo, Kevin H
Publicado no Glycobiology (2016)

A Novel Colonic Repressor Element Regulates Intestinal Gene Expression by Interacting with Cux/CDP

Por Boudreau, François, Rings, Edmond H. H. M., Swain, Gary P., Sinclair, Angus M., Suh, Eun Ran, Silberg, Debra G., Scheuermann, Richard H., Traber, Peter G.
Publicado em 2002

Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 random...

Por Harrison, Stephen A., Dennis, Andrea, Fiore, Martine M., Kelly, Matt D., Kelly, Catherine J., Paredes, Angelo H., Whitehead, Jennifer M., Neubauer, Stefan, Traber, Peter G., Banerjee, Rajarshi
Publicado no PLoS One (2018)